Inhibiting CAF autophagy suppresses tumor development and enhances anti-tumor immunity by reducing CD274/PDL1 expression in PDAC, with targeted CAF autophagy inhibition via chloroquine diphosphate-loaded MSC-liposomes improving immunochemotherapy efficacy. This evidence concerns the gene CD274 and neoplasm.